NAFLD & NASH: Epidemiology & Burden, Risk Factors and Pathophysiology

• NAFLD & NASH: Introduction & Disease Burden
• Current Gaps in NASH Awareness
• NAFLD & NASH: Epidemiology & Risk Factors
• Pathophysiology, Disease Progression & Complications
• The Role of Insulin Resistance in NASH
• Epidemiology & Risk Factors: A Deeper Dive

NASH: Screening, Diagnosis, and Current Treatment Options

• NASH: Diagnosis & Risk Stratification
• Emerging Non-Invasive Diagnostic Algorithms 
• Management of NASH: Lifestyle Modifications
• Overview of Guidelines, Current, and Select Emerging Treatment Options

NAFLD & NASH Diagnosis: A Deeper Dive

• Diagnosis of NAFLD: From Invasive to Non-Invasive: An Overview
• NAFLD and T2DM
• Diagnosis of Steatosis and Fibrosis in NAFLD/NASH
• Diagnosis and Management of NAFLD/NASH: A 2022 Update
• Emerging Biomarkers and Diagnostic Tools

Current Treatments for NASH: A Deeper Dive

• Current Treatments for NASH: An Introduction
• Role of Lifestyle Modifications in NASH Resolution
• Role of GLP-1 RAs and SGLT-2 Inhibitors in NASH Resolution
• Role of Pioglitazone in NASH Resolution

Future Treatments for NASH

• New Targets and Treatments for NASH
• Novel GLP-1 RAs for NASH
• Potential Role of FGF-19, FGF-21, and Thyroid Hormone Receptor Beta Selective Agonists in NASH
• Potential Role of FXR Agonists in NASH
• Summary of Novel Agents for the Treatment of NASH